BNB PLUS CORP.

STONY BROOK, NY · Biotech · Public

DNA-based molecular tagging and tracking technology for product authentication and supply chain verification

Claim this profile

Follows are private to you and power your alerts

Updated Oct 23, 2026 · applieddna.com

Sector: Biotech
Headquarters: STONY BROOK, NY
Latest Form D: $2.5M, Jun 2026
Total capital: $99.9M

Federal grants: None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised: $91.9M; 20 Form D · last Jun 2026; 5 months since last filing
Federal contracts: $8M; 70 awards · Defense, State, Federal Trade Comm; Rank in Biotech#65 of 4373
Granted patents: 2; 26 pending · first 2016

Capital timeline

Latest events

Jun 2026Private capital raisedForm D · SEC · 20th filing$2.5M
May 2026Federal contractDefense · 8512093939!MISCELLANEOUS$21K
Dec 2025Federal contractDefense · 8511815261!MISCELLANEOUS$1
Oct 2025Private capital raisedForm D · SEC · 19th filing$58M
Sep 2025Federal contractDefense · 8511644365!MISCELLANEOUS$36K
Jun 2025Federal contractDefense · 8511450976!MISCELLANEOUS$36K
Mar 2025Federal contractDefense · 8511273757!MISCELLANEOUS$36K
Nov 2024Offering registeredForm D · SEC · 18th filing$13.3M
Feb 2024Offering registeredForm D · SEC · 17th filing$6.9M
Oct 2020Private capital raisedForm D · SEC · 16th filing$1.2M
Aug 2019Private capital raisedForm D · SEC · 15th filing$418K
Jul 2019Private capital raisedForm D · SEC · 14th filing$1.5M
Sep 2018Private capital raisedForm D · SEC · 13th filing$1.6M
Jul 2017Private capital raisedForm D · SEC · 12th filing$805K
Nov 2016Private capital raisedForm D · SEC · 11th filing$5M
Dec 2015Private capital raisedForm D · SEC · 10th filing$25K
Sep 2014Private capital raisedForm D · SEC · 9th filing$1.8M
Jun 2014Private capital raisedForm D · SEC · 8th filing$2.1M
Aug 2013Private capital raisedForm D · SEC · 7th filing$7.5M
Dec 2012Private capital raisedForm D · SEC · 6th filing$2M
Jul 2012Private capital raisedForm D · SEC · 5th filing$1.5M
Jul 2011Private capital raisedForm D · SEC · 4th filing$5M
Nov 2010Private capital raisedForm D · SEC · 3rd filing$350K
Jul 2010Offering registeredForm D · SEC · 2nd filing$2M
Jun 2009Private capital raisedForm D · SEC · 1st filing$450K

Show 65 earlier federal awards

Dec 2024Federal contractDefense · 8511082660!MISCELLANEOUS$36K
Sep 2024Federal contractDefense · 8510924633!MISCELLANEOUS$36K
Sep 2024Federal contractDefense · 8510924438!MISCELLANEOUS$1
Jun 2024Federal contractDefense · 8510717559!MISCELLANEOUS$36K
Mar 2024Federal contractDefense · 8510527179!MISCELLANEOUS$36K
Dec 2023Federal contractDefense · 8510320745!MISCELLANEOUS$36K
Sep 2023Federal contractDefense · 8510131166!MISCELLANEOUS$36K
Jun 2023Federal contractDefense · 8509939310!MISCELLANEOUS$36K
Mar 2023Federal contractDefense · 8509763352!MISCELLANEOUS$36K
Dec 2022Federal contractDefense · 8509584086!MISCELLANEOUS$36K
Sep 2022Federal contractDefense · 8509394162!MISCELLANEOUS$45K
Jun 2022Federal contractDefense · 8509179040!MISCELLANEOUS$45K
Mar 2022Federal contractDefense · 8508937052!MISCELLANEOUS$45K
Dec 2021Federal contractDefense · 8508730487!MISCELLANEOUS$45K
Aug 2021Federal contractDefense · 8508482664!MISCELLANEOUS$42K
May 2021Federal contractDefense · 8508246169!MISCELLANEOUS$42K
Feb 2021Federal contractDefense · 8508006894!MISCELLANEOUS$42K
Nov 2020Federal contractDefense · 8507811448!MISCELLANEOUS$42K
Sep 2020Federal contractDefense · 8507619663!MISCELLANEOUS$42K
May 2020Federal contractDefense · 8507392312!MISCELLANEOUS$42K
Mar 2020Federal contractDefense · 8507236089!MISCELLANEOUS$500
Feb 2020Federal contractDefense · 8507168313!MISCELLANEOUS$42K
Nov 2019Federal contractDefense · 8506974212!MISCELLANEOUS$42K
Sep 2019Federal contractState · The Order Is For Laboratory Testing And Security Marking Supplies.$45K
Aug 2019Federal contractDefense · 8506755105!MISCELLANEOUS$42K
May 2019Federal contractDefense · 8506557719!MISCELLANEOUS$42K
Mar 2019Federal contractDefense · 8506335058!MISCELLANEOUS$42K
Nov 2018Federal contractDefense · 8506061850!MISCELLANEOUS$42K
Sep 2018Federal contractDefense · 8505888356!MISCELLANEOUS$42K
Jul 2018Federal contractDefense · 8505672894!MISCELLANEOUS$250
Jun 2018Federal contractDefense · 8505566296!MISCELLANEOUS$42K
Feb 2018Federal contractDefense · 8505215490!MISCELLANEOUS$42K
Nov 2017Federal contractDefense · 8504977024!MISCELLANEOUS$42K
Aug 2017Federal contractDefense · 8504700289!MISCELLANEOUS$42K
Jun 2017Federal contractDefense · 8504503361!MISCELLANEOUS$42K
Jun 2017Federal contractDefense · IGF::OT::IGF!8504409043!SERVICES - Basic$1.5M
Mar 2017Federal contractDefense · 8504199555!MISCELLANEOUS$44K
Dec 2016Federal contractDefense · 8503928818!MISCELLANEOUS$44K
Sep 2016Federal contractState · External/internal Asset Marking Liquid$71K
Sep 2016Federal contractDefense · 8503625954!MISCELLANEOUS$74K
Jul 2016Federal contractDefense · 8503426835!MISCELLANEOUS$5K
Jun 2016Federal contractDefense · 8503372237!MISCELLANEOUS$21K
Jun 2016Federal contractDefense · 8503363217!MISCELLANEOUS$40K
Jun 2016Federal contractDefense · 8503305208!MISCELLANEOUS$3K
Apr 2016Federal contractState · Dna Markers$23K
Mar 2016Federal contractDefense · 8503027997!MISCELLANEOUS$4K
Feb 2016Federal contractDefense · 8502979906!MISCELLANEOUS$60K
Dec 2015Federal contractDefense · 8502769053!MISCELLANEOUS$56K
Dec 2015Federal contractDefense · 8502747457!MISCELLANEOUS$18K
Nov 2015Federal contractDefense · 8502654314!MISCELLANEOUS$4K
Sep 2015Federal contractDefense · 8502563629!MISCELLANEOUS$56K
Sep 2015Federal contractDefense · 8502483829!MISCELLANEOUS$4K
Sep 2015Federal contractDefense · 8502483750!MISCELLANEOUS$4K
Aug 2015Federal contractFederal Trade Comm · Expert Services: Igf::ot::igf$6K
Aug 2015Federal contractDefense · 8502388119!MISCELLANEOUS$4K
Jun 2015Federal contractDefense · 8502254100!MISCELLANEOUS$60K
Jun 2015Federal contractDefense · 8502169254!MISCELLANEOUS$4K
Mar 2015Federal contractDefense · 8501862832!MISCELLANEOUS$60K
Dec 2014Federal contractDefense · 8501636239!MISCELLANEOUS$28K
Dec 2014Federal contractDefense · 8501636119!MISCELLANEOUS$4K
Oct 2014Federal contractDefense · 8501473824!MISCELLANEOUS$9K
Sep 2014Federal contractState · Signature Dna Marking Program&digital Dna Asset Tracking (1-YR) Igf::ot::igf$252K
Aug 2014Federal contractDefense · Igf::ot::igf Defense Logistics Agencey Rapid Innovation Fund Contract, Research And Development. Proposal #: DODRIF13-DLA02-P-0005, Title: "anti-counterfeiting Protection: Single Authentication Technology For Multiple High-risk Commodities."$3M
Jul 2014Federal contractDefense · Igf::ot::igf SBIR Phase II Research And Development. Proposal Title: Marking Of Components For Avoidance Of Counterfeit Parts.$975K
Apr 2013Federal contractDefense · SBIR Ph I Research&development Basic Contract; Marking Of Components For Avoidance Of Counterfeit Parts Igf::ot::igf$150K

Federal awards are summed by year (70 awards); hover a bar for the split. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Founders and team

From SEC Form D filings

Beth JantzenExecutive OfficerNamed in SEC Form D filings
CHARLES BENJAMIN RYANDirectorNamed in SEC Form D filings
Clay A. ShorrockExecutive OfficerNamed in SEC Form D filings
Elizabeth M. Schmalz FergusonDirectorNamed in SEC Form D filings
Elizabeth M. Schmalz ShaheenDirectorNamed in SEC Form D filings
GERALD BENJAMIN CATENACCIDirectorNamed in SEC Form D filings

Show all 18 people

JAMES A HAYWARDExecutive Officer, DirectorNamed in SEC Form D filings
John A. Bitzer, IIIDirectorNamed in SEC Form D filings
Joseph D. CeccoliDirectorNamed in SEC Form D filings
Judith A. MurrahExecutive OfficerNamed in SEC Form D filings
Judy BENJAMIN MurrahExecutive OfficerNamed in SEC Form D filings
KAROL BENJAMIN GRAYDirectorNamed in SEC Form D filings
Kurt H. JensenExecutive OfficerNamed in SEC Form D filings
Ming-Hwa Benjamin LiangExecutive OfficerNamed in SEC Form D filings
Robert B. CatellDirectorNamed in SEC Form D filings
Sanford R. SimonDirectorNamed in SEC Form D filings
Scott D. AnchinDirectorNamed in SEC Form D filings
YACOV A SHAMASHDirectorNamed in SEC Form D filings

What it has protected

USPTO · 2 granted of 28

Jan 30, 2025PendingMethods and vectors for in vitro transcription of mRNA with reduced levels of dsRNAUSPTOApplication 18740403
Dec 19, 2024PendingMethods For Genetic Analysis Of Textiles Comprising G. BarbadenseUSPTOApplication 18703558
Sep 28, 2023PendingMethods and Systems of Producing Single Stranded DNA via PCR Using Biotin-Labeled PrimersUSPTOApplication 18095785

Show all 28 patent records

Methods and vectors for in vitro transcription of mRNA with reduced levels of dsRNAJan 30, 2025 · Application 18740403Pending
Methods For Genetic Analysis Of Textiles Comprising G. BarbadenseDec 19, 2024 · Application 18703558Pending
Methods and Systems of Producing Single Stranded DNA via PCR Using Biotin-Labeled PrimersSep 28, 2023 · Application 18095785Pending
System And Method For On-site Authentication Of Nucleic Acid Taggants Using Nucleic Acid Lateral Flow DeviceAug 17, 2023 · Application 18110659Pending
Method of Marking Cellulosic ProductsJan 4, 2022 · US 11,214,928Granted
Compositions And Methods For Detecting And Treating SARS-COV-2Sep 23, 2021 · Application 17206681Pending
Use Of Perturbants To Facilitate Incorporation And Recovery Of Taggants From Polymerized CoatingsMar 29, 2016 · US 9,297,032Granted
Dna Marking Of Previously Undistinguished Items For TraceabilitySep 18, 2014 · Application 13796663Pending
Security System And Method Of Marking An Inventory Item And/or Person In The VicinityApr 17, 2014 · Application 13652781Pending
Plasma Treatment For Dna BindingApr 17, 2014 · Application 13836238Pending
Laser Marking For Authentication And TrackingApplication PCTUS2014034642Pending
Dna Marking Of Previously Undistinguished Items For TraceabilityApplication PCTUS2014023928Pending
Alkaline Activation For Immobilization Of Dna TaggantsApplication PCTUS2014021207Pending
Security System And Method Of Marking An Inventory Item And/or Person In The VicinityApplication PCTUS2013065161Pending
Use Of Perturbants To Facilitate Incorporation And Recovery Of Taggants From Polymerized CoatingsApplication PCTUS2013064194Pending
Methods For Genotyping Mature Cotton Fibers And TextilesApplication PCTUS2009063818Pending
Methods For Genetic Analysis Of Textiles Made Of Gossypium Barbadense And Gossypium Hirsutum CottonApplication PCTUS2009063814Pending
System And Method For Authenticating Multiple Components Associated With A Particular ProductApplication PCTUS2006019660Pending
System And Method For Marking Textiles With Nucleic AcidsApplication PCTUS2004012031Pending
Methods For Genetic Analysis Of Textiles Comprising G. BarbadenseApplication PCTUS2022047411Pending
System And Method For On-site Authentication Of Nucleic Acid Taggants Using Nucleic Acid Lateral Flow DeviceApplication 63310732Pending
Methods and Systems of Producing Single Stranded DNA via PCR Using Biotin-Labeled PrimersApplication 63299684Pending
Compositions And Methods For Detecting And Treating SARS-COV-2Application PCTUS2021023131Pending
Composition And Methods For Detecting SARS-COV-2 In A SampleApplication 63019792Pending
Composition And Methods For Detecting SARS-COV-2 In A SampleApplication 62992235Pending
Pcr-based Single Polarity Recombinant Adeno-associated Virus ManufactureApplication 62916333Pending
Methods And Systems Of Pcr-based Recombinant Adeno-associated Virus ManufactureApplication 62883701Pending
Composition and Method of DNA Marking Elastomeric MaterialApplication 62407819Pending

Noveome Biotherapeutics, Inc.Similar federal contract value in Biotech · $8.5M in contracts
Ionis PharmaceuticalsSimilar federal contract value in Biotech · $8.4M in contracts
ARISAN THERAPEUTICS INCSimilar federal contract value in Biotech · $8.3M in contracts
DISCOVERX CORPSimilar federal contract value in Biotech · $7.6M in contracts
PROSCI, INC.Similar federal contract value in Biotech · $7.5M in contracts
Inhibikase Therapeutics, Inc.Similar federal contract value in Biotech · $7.1M in contracts

Regulatory activity · Biotech

Sector-level, not company-level

07 Jul 2026New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
30 Jun 2026Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
30 Jun 2026Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
29 Jun 2026Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
26 Jun 2026Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
26 Jun 2026Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through Oct 23, 2026. SBIR and STTR awards through Oct 21, 2026.